To participate in Study, you must be:
- 50 to 90 years of age
- Currently Diagnosed with probable Alzheimer's Disease
- Receiving background therapy of Donepezil or Rivastigmine for at least 6 months
- Generally healthy and ambulatory or ambulatory-aided (Walker or Cane)
- In frequent contact with a caregiver, family, social worker, case worker, or nurse
Phone for more information...